Difference between revisions of "Prescription Medication"

From Pheno Wiki
Jump to: navigation, search
(Serotonin Reuptake Inhibitors)
Line 34: Line 34:
  
 
Escitalopram is often given to children to improve repetitive behaviors in those with ASD, although a recent large study has questioned its efficacy<sup>3</sup>.Response to the drug may depend on the individual's genotype of the serotonin transporter, which could explain the lack of efficacy in a large group sample. A minority of the children experienced drug-induced insomnia, hyperactivity, and or general disinhibition, even at low doses.<sup>4</sup>  
 
Escitalopram is often given to children to improve repetitive behaviors in those with ASD, although a recent large study has questioned its efficacy<sup>3</sup>.Response to the drug may depend on the individual's genotype of the serotonin transporter, which could explain the lack of efficacy in a large group sample. A minority of the children experienced drug-induced insomnia, hyperactivity, and or general disinhibition, even at low doses.<sup>4</sup>  
----
+
 
 
<br><br><br><br>
 
<br><br><br><br>
 
<div style="float:left; padding:10px; background:yellow; border:2px solid black;font-size:large;">[[AIRB| Back to Main Page]]</div>
 
<div style="float:left; padding:10px; background:yellow; border:2px solid black;font-size:large;">[[AIRB| Back to Main Page]]</div>

Revision as of 11:11, 17 June 2010

Prescription Medication

Description

A variety of prescription medication is commonly prescribed by clinicians to treat various symptoms such as depression, repetitive behaviors, epilepsy, psychosis in ASD children. Many safety and efficacy studies are underway for this population, though most clinicians say that from experience those with ASD tend to have side effects more often and of a more severe nature than the typically developing population.

Antidepressants

Antidepressants should be used with with increased caution for children with ASD because of the current FDA warning for increased suicidal thinking and behavior for children taking antidepressants, as well as the tendency for children with ASD to experience side effects more frequently and more severely than the typically developing population. Usually, antidepressants prescribed are serotonin selective re-uptake inhibitors (SSRIs). Side effects include nausea, sedation, activation, agitation, insomnia, and sometimes increased activity, increased anxiety, or mood lability. ASD children tend to have greater disinhibition when taking antidepressants. Activation also happens more frequently in ASD children (one study had a 20% activation rate among ASD subjects).

The best management strategy to avoid activation in this population is to use the lowest effective dose and to slow the titration schedule (much less than the schedule used in adults).

Medications which have neurological side effects such as Clomipramine should be used with caution in ASD patients because children with ASD may be at higher risk to experience neurological side effects since many in this population also suffer from seizures.

Stimulants

Controlled studies suggest that there is an elevated risk of adverse events such as confusion, possible psychosis, and treatment emergent tic disorder occurring for children with ASD who take stimulants compared to typically developing children with other disorders including ADHD. Studies involving children with ASD to test the safety and efficacy of stimulants in this population show a much higher dropout rate than for the typically developing population. Reasons cited for dropping out are usually from negative mood effects. Additionally, children with ASD report a higher rate of insomnia in studies when taking medium ( 0.25 mg/kg/dose) and high doses (0.5mg/kg/dose) as well as a reduction in appetite.

Some suggestions for management in this population include extended-release preparations for medications rather than those that are rapidly releasing. Patients prescribed stiumulants should be monitored closely for side effects using a structured measure, such as growth in height. If growth drops off too quickly, the clinician should reconsider using stimulants.

Second Generation Antipsychotics

Adverse effects from using second generation antipsychotics include sedation, increased appetite, weight gain, disrupted sleep, prolactin elevation, and extrapyramidal symptoms. However, some side effects such as sedation seem to fade with time. Low doses appear to be highly effective from studies and they also tend to have a lower risk of side effects than higher doses.

Serotonin Reuptake Inhibitors

Fluoxetine

Fluoxetine is a FDA approved drug for the treatment of OCD and depression in children. In the only double-blind placebo-controlled crossover study of using this drug in children with autism, they decided that Fluoxetine was superior to the placebo in reducing repetitive behaviors when measured by the CY-BOCS. Low-dosages of fluoxetine was slighly superior to placebo in reducing global autism severity when measured by the GACIM scale. Further analysis of this drug in another study showed that positive fluoxetine response in autistic children correlated with family history of major affective disorders, unusual intellectual achievement, and hyperlexia, which may suggest that this drug works best for a genetically defined subtype of autism. 2

Fluvoxamine

Fluvoxamine is a FDA approved drug for the treatment of OCD in adults and children. In an open label study to assess the overall effectiveness and tolerability of fluboxamine, the effect of puberty on drug response, an the relationship of changes in platelet serotonin to behavioral response in 18 children. The drug had no statistically significant improvement for autistic children in global functioning, repetitive behaviors. or anxiety symptoms. Side effects were notable from the drug. Different ethnic groups also display different responses to this drug. 2

Escitalopram

Escitalopram is often given to children to improve repetitive behaviors in those with ASD, although a recent large study has questioned its efficacy3.Response to the drug may depend on the individual's genotype of the serotonin transporter, which could explain the lack of efficacy in a large group sample. A minority of the children experienced drug-induced insomnia, hyperactivity, and or general disinhibition, even at low doses.4





Back to Main Page






References

1. McCracken, J.T. Safety issues with drug therapies for Autism Spectrm Disorders. Journal of Clinical Psychiatry 2005; 66 (suppl 10).

2. West L et. al. Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors.J Spec Pediatr Nurs. 2009 Jul;14(3):183-91. PMID 19614827

3. King BH et.al. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.Arch Gen Psychiatry. 2009 Jun;66(6):583-90. PMID 19487623

4. Owley T et. al. A pharmacogenetic study of escitalopram in autism spectrum disorders.Autism Res. 2010 Feb;3(1):1-7. PMID 20020537